Caribou Biosciences Inc.
CRBU | NASDAQ
$1.33
+$0.03 (+2.31%)
Sep 22, 2026, 1:14 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.5M | 2.4M | 3.94M | 2.2M | 2.67M | 2.35M | 2.08M | 2.02M | 3.46M | 2.43M | 3.56M | 23.66M | 3.76M | 3.5M | 3.69M | 3.3M | 4.19M | 2.66M | 2.56M | 3.98M | 1.48M | 1.59M |
Cost of Revenue | n/a | 649K | n/a | 22.4M | 1.3M | 1.74M | 29.86M | 29.82M | 856K | 710K | 1.97M | 28.58M | 26.5M | 25.71M | 25.74M | n/a | 22.58M | 13.92M | 273K | 15.83M | 12.33M | 10.17M |
Gross Profit | 1.5M | 1.75M | 3.94M | -20.2M | 1.37M | 610K | -27.79M | -27.8M | 2.61M | 1.72M | 1.58M | -4.92M | -22.75M | -22.21M | -22.04M | 3.3M | -18.39M | -11.26M | 2.29M | -11.86M | -10.85M | -8.58M |
Operating Income | -25.34M | -26.28M | -28.45M | -29.4M | -47.58M | -42.91M | -38.88M | -38.24M | -43.5M | -46M | -37.44M | -14.63M | -32.87M | -31.12M | -30.58M | -26.54M | -28.43M | -20.85M | -20.41M | -18.62M | -15.96M | -13.18M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.77M | n/a | n/a | n/a | n/a | n/a | 251K | 76K | 22K | 46K | 4K |
Pretax Income | -24.28M | -25.09M | -27.04M | -27.55M | -54.1M | -39.99M | -35.5M | -34.68M | -37.7M | -41.23M | -34.31M | -10M | -29.52M | -28.04M | -26.92M | -26.65M | -26.7M | -19.09M | -18.16M | -20.97M | -14.31M | -13.16M |
Net Income | -24.28M | -25.09M | -26.49M | -27.55M | -54.1M | -39.99M | -35.49M | -34.68M | -37.7M | -41.23M | -34.51M | -10M | -29.52M | -28.04M | -26.99M | -26.65M | -26.7M | -19.09M | -18.48M | -20.97M | -14.31M | -13.16M |
Selling & General & Admin | 7.9M | 8.07M | 8.58M | 9.2M | 10.4M | 9.74M | 10.49M | 5.94M | 10.63M | 14.64M | 7.75M | 9.71M | 10.12M | 8.91M | 8.53M | 9.85M | 10.04M | 9.59M | 7.58M | 6.76M | 5.11M | 4.6M |
Research & Development | 18.94M | 20.61M | 23.82M | 22.4M | 27.69M | 35.53M | 30.46M | 30.42M | 35.48M | 33.79M | 31.28M | 28.58M | 26.5M | 25.71M | 26.34M | 19.99M | 22.58M | 13.92M | 15.11M | 15.83M | 12.33M | 10.17M |
Other Expenses | n/a | -649K | n/a | -22.4M | 10.85M | -1.74M | -29.86M | -25.92M | n/a | -710K | n/a | -28.58M | -26.5M | -25.71M | -26.34M | n/a | -22.58M | -13.92M | n/a | -15.83M | -12.33M | -10.17M |
Operating Expenses | 26.84M | 28.03M | 32.39M | 9.2M | 48.95M | 43.52M | 11.09M | 10.44M | 46.11M | 47.72M | 39.03M | 9.71M | 10.12M | 8.91M | 8.53M | 29.84M | 10.04M | 9.59M | 22.69M | 6.76M | 5.11M | 4.6M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 5K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -856K | n/a | -1.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 26.84M | 28.68M | 32.39M | 31.6M | 50.25M | 45.27M | 40.95M | 40.26M | 46.97M | 48.43M | 41M | 38.3M | 36.62M | 34.62M | 34.27M | 29.84M | 32.62M | 23.52M | 22.96M | 22.59M | 17.44M | 14.76M |
Income Tax Expense | n/a | n/a | -550K | n/a | n/a | n/a | -9K | n/a | n/a | n/a | 193K | n/a | n/a | n/a | 70K | n/a | n/a | n/a | 321K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 100.99M | 95.86M | 94.54M | 93.29M | 93.03M | 92.68M | 90.32M | 90.46M | 90.34M | 89.3M | 88.43M | 83.78M | 61.42M | 61.19M | 61M | 60.89M | 60.76M | 60.55M | 60.18M | 45.89M | 54.71M | 27.66M |
Shares Outstanding (Diluted) | 100.99M | 95.86M | 94.54M | 93.29M | 93.03M | 92.68M | 90.32M | 90.46M | 90.34M | 89.3M | 88.43M | 83.78M | 61.42M | 61.19M | 61M | 60.89M | 60.76M | 60.55M | 60.18M | 45.89M | 54.71M | 27.66M |
EPS (Basic) | -0.24 | -0.26 | -0.28 | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 | -0.42 | -0.46 | -0.39 | -0.12 | -0.48 | -0.46 | -0.44 | -0.44 | -0.44 | -0.32 | -0.31 | -0.46 | -0.26 | -0.48 |
EPS (Diluted) | -0.24 | -0.26 | -0.28 | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 | -0.42 | -0.46 | -0.39 | -0.12 | -0.48 | -0.46 | -0.44 | -0.44 | -0.44 | -0.32 | -0.31 | -0.46 | -0.26 | -0.48 |
EBITDA | -26.4M | -24.44M | -26.36M | -26.92M | -34.26M | -38.83M | -37.09M | -33.51M | -36.84M | -40.52M | -33.57M | -8.42M | -28.9M | -27.46M | -26.41M | -26.2M | -26.34M | -18.78M | -17.89M | -20.71M | -14.08M | -12.95M |
EBIT | -26.4M | -25.09M | -27.04M | -27.55M | -35.43M | -39.99M | -38.28M | -34.68M | -37.7M | -41.23M | -34.31M | -10M | -29.52M | -28.04M | -26.92M | -26.65M | -26.7M | -19.09M | -18.16M | -20.97M | -14.31M | -13.18M |
Depreciation & Amortization | n/a | 649K | 682K | 631K | 1.17M | 1.17M | 1.18M | 1.18M | 856K | 710K | 740K | 1.58M | 617K | 589K | 506K | 450K | 358K | 308K | 273K | 260K | 230K | 221K |
Add to Watchlist
Select watchlists to add or remove CRBU